Overview

Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.

Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
0
Participant gender:
All
Summary
Comparison between FDG-PET and MRI for the assessment of response to intensive chemotherapy in multiple myeloma patients.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nantes University Hospital
Treatments:
Fluorodeoxyglucose F18
Criteria
Inclusion Criteria:

- Patients from 18 to 65 years old.

- De novo histologically proven multiple myeloma.

Exclusion Criteria:

- No history of another cancer or of HIV

- No history of renal failure